FUJIFILM
富士フイルム
Business focus
MedTech, BioTech & Pharma
Description
FUJIFILM entered regenerative medicine mainly through its 2015 acquisition of Cellular Dynamics International (Wisconsin, USA), now FUJIFILM Cellular Dynamics (FCDI) — a leading developer/manufacturer of human induced pluripotent stem (iPS) cell technology, with cGMP facilities in Madison for iPSC manufacturing and therapeutic programs targeting Parkinson's disease, heart failure, cancer immunotherapy and retinal disease. FUJIFILM also sells NAD+/anti-aging supplement lines through its Japanese cosmetics/health-science business; specific NAD+ product revenue figures were not found in available sources.